SCHEMBL8796708

SCHEMBL8796708

Cc1nc(-c2ccc(F)cc2)c(-c2sccc2C)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.55
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2A6 P11509 2/20 0.45
CYP2B6 P20813 1/20 0.45
KDM4E B2RXH2 3/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP1A2 P05177 1/20 0.43
CDK4 P11802 1/20 0.39
PTGS1 P23219 6/20 0.39
MAPK14 Q16539 2/20 0.39
MAPT P10636 2/20 0.37
RAB9A P51151 1/20 0.37
GFER P55789 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8797216 0.88 PTGS2 (0.55) PTGS2CYP3A4CYP2C19CYP2A6CYP2B6
SCHEMBL693906 0.76 CYP2A6 (0.59) PTGS2CYP3A4CYP2C19CYP2A6CYP2B6
SCHEMBL7163500 0.74 PTGS1 (0.58) PTGS2CYP3A4CYP2C19CYP2A6CYP2B6
SCHEMBL7844988 0.74 PTGS2 (0.52) PTGS2KDM4EMEN1ALDH1A1KMT2A
SCHEMBL8188473 0.73 ALDH1A1 (0.61) PTGS2ALDH1A1CDK4MAPK14HPGD
SCHEMBL7833390 0.73 PTGS2 (0.62) PTGS2KDM4EPTGS1MAPK14MAPT
SCHEMBL7844983 0.73 PTGS2 (0.62) PTGS2KDM4EPTGS1MAPK14MAPT
SCHEMBL4552990 0.71 KDM4E (0.67) CYP3A4CYP2C19KDM4EMEN1ALDH1A1
SCHEMBL3242265 0.71 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL213779 0.71 PTGS2 (1.00) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed